Not yet recruiting
Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese Patients
NCT07847515· Nanjing First Hospital, Nanjing Medical University· Source
Contact: ZongDan Jiang
Not yet recruiting
A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)
NCT07915219· Phase 3· Boehringer Ingelheim· Source
Contact: Boehringer Ingelheim
Not yet recruiting
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
NCT07881432· Phase 3· Eli Lilly and Company· Source
Contact: Qian Li (principal investigator)
Not yet recruiting
A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems
NCT07790861· Phase 3· Eli Lilly and Company· Source
Contact: Qian Li (principal investigator)
Not yet recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
NCT07900633· Phase 3· Eli Lilly and Company· Source
Contact: Qian Li (principal investigator)
Not yet recruiting
Reduced-Dose Thrombolysis in Intermediate-Risk Pulmonary Embolism With High-Risk Features
NCT07917078· Phase 3· China National Center for Cardiovascular Diseases· Source
Contact: He Xu, Prof.
Recruiting
Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure
NCT07575672· Phase 3· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Junjie Zhang, MD
Recruiting
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
NCT07541170· Phase 3· Hoffmann-La Roche· Source
Recruiting
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
NCT07717411· Phase 3· Hoffmann-La Roche· Source
Recruiting
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity
NCT07792954· Phase 3· Pfizer· Source
Recruiting
The Effect of Remimazolam Tosylate on the Incidence of Postoperative Delirium in Older Patients Undergoing Cardiac Surgery: A Prospective Randomized Controlled Trial
NCT07908121· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Shu li Zhao
Not yet recruiting
PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke
NCT07466251· Phase 4· Peking Union Medical College Hospital· Source
Contact: Weihai Xu, MD
Recruiting
Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease
NCT07764094· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Fei Ye, MD
Recruiting
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
NCT07794579· Phase 3· Eli Lilly and Company· Source
Contact: Qian Li (principal investigator)
Recruiting
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
NCT07214376· Pulnovo Medical, Inc.· Source
Contact: Hang Zhang
Recruiting
Analgesic Effects of Retro-superior Costotransverse Ligament Space Block for Video-assisted Thoracoscopic Surgery
NCT07745881· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Tao Shan
Recruiting
68Ga-labeled Cholecystokinin Receptor (CCK2R) Targeted Molecular Probes in Early Tumor Diagnosis
NCT07914764· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Feng Wang, M.D.
Not yet recruiting
Home-Based Supportive Care Program for NMIBC Patients Receiving Intravesical Perfusion: Construction and Preliminary Application
NCT07781956· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Chunhua Zheng, Bachelor
Recruiting
Progression, Management, and Clinical Outcomes of Coronary Artery Aneurysms
NCT07764081· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Fei Ye, MD
Recruiting
Keverprazan-Minocycline Dual Therapy of Different Durations Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication.
NCT07904429· Phase 3· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Zhenyu Zhang
Not yet recruiting
STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonary Embolism
NCT07603700· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Interventional Vascular Department Director, doctor
Recruiting
A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
NCT07404553· Phase 2/3· Beijing Suncadia Pharmaceuticals Co., Ltd· Source
Contact: Shaoliang Chen
Recruiting
Phase II Study of RC1416 Injection in COPD
NCT07402551· Phase 2· Nanjing RegeneCore Biotech Co., Ltd.· Source
Contact: Surong Fang
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
NCT07392190· Phase 3· Eli Lilly and Company· Source
Contact: Qian Li (principal investigator)
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
NCT07369011· Phase 3· Eli Lilly and Company· Source
Contact: Qian Li (principal investigator)
Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
NCT07353931· Phase 3· Eli Lilly and Company· Source
Contact: Qian Li (principal investigator)
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
NCT07321886· Phase 3· Eli Lilly and Company· Source
Contact: Qian Li (principal investigator)
Recruiting
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
NCT07063745· Phase 2/3· Bristol-Myers Squibb· Source
Contact: Surong Fang, Site 0386
Recruiting
Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial
NCT07349875· Phase 4· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Nanjing First Hospital
Not yet recruiting
Safety and Efficacy of DCB Therapy for de Novo Lesions Under the Guidance of QFR in CHD Patients (UNIQUE-DCB-I Study )
NCT04104854· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Fei Ye, MD
Not yet recruiting
Safety and Efficacy of DCB Therapy for ISR Under the Guidance of QFR (UNIQUE-DCB-II Study )
NCT04119986· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Jie Zhou
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
NCT07282600· Phase 3· Eli Lilly and Company· Source
Contact: Qian Li (principal investigator)
Recruiting
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
NCT07241390· Phase 3· Eli Lilly and Company· Source
Contact: Qian Li (principal investigator)
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
NCT07223593· Phase 3· Eli Lilly and Company· Source
Contact: Qian Li (principal investigator)
Active, not recruiting
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07169578· Phase 3· Hoffmann-La Roche· Source
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
NCT07153471· Phase 3· Eli Lilly and Company· Source
Recruiting
Local Anaesthetic Spread and Sensory Block Range of the Retro-superior Costotransverse Ligament Space Block
NCT07153263· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Tao Shan, MD
Not yet recruiting
Radiolabeled TSPO Targeted Molecular Probe in Alzheimer's Disease.
NCT07105956· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Feng Wang
Active, not recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433· Phase 3· Amgen· Source
Not yet recruiting
The Effect of Bupivacaine Liposome Preemptive Analgesia on Postoperative Pain and Delirium in Elderly Patients Undergoing Hip Fracture Surgery
NCT07066111· Phase 4· Nanjing First Hospital, Nanjing Medical University· Source
Contact: YiHong Gao
Active, not recruiting
Application of Pericapsular Nerve Group (PENG) Block
NCT07078773· Nanjing First Hospital, Nanjing Medical University· Source
Recruiting
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
NCT07177352· Phase 3· Hoffmann-La Roche· Source
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT06872892· Phase 3· Boehringer Ingelheim· Source
Contact: Boehringer Ingelheim
Not yet recruiting
Biomarkers of Clopidogrel Resistance for Predicting Ischemic Recurrence After Cerebral Artery Stenting
NCT07028775· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Ting Tai, Doctor
Not yet recruiting
The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture
NCT06901492· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Hongbin Sun, MD, PHD
Recruiting
Nasopharyngeal Airway Combined With Nasal High-flow Oxygen Therapy During Painless Gastroscopy in Obesity Patients
NCT06966934· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Tao Shan, MD
Active, not recruiting
Effects of Neuromuscular Electrical Stimulation Combined With Ultrasound on Stroke Patients With Sarcopenia
NCT07708597· Nanjing First Hospital, Nanjing Medical University· Source
Recruiting
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
NCT06860971· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source
Contact: Feng Wang, Doctor
Recruiting
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
NCT06937112· Nanjing First Hospital, Nanjing Medical University· Source
Contact: Feng Wang, M.D.
Not yet recruiting
A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment
NCT06922929· Phase 3· Yunhe Pharmaceutical (Tianjin) Co., Ltd· Source
Contact: Dong Yuan
Showing 50 of 81.